Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde, also known as 1-Boc-piperidine-4-carboxaldehyde, is a clear yellow oil with chemical properties that make it a versatile reactant in the synthesis of various compounds. It is a significant intermediate in the pharmaceutical industry due to its ability to be used in the creation of multiple therapeutic agents.

137076-22-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 137076-22-3 Structure
  • Basic information

    1. Product Name: 1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde
    2. Synonyms: 1-(tert-butoxycarbonyl)-4-formylpiperidine;1-BOC-4-FORMYLPIPERIDINE 95%;1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde;1-TERT-BUTOXYCARBONYLPIPERIDINE-4-CARBOXALDEHYDE;Piperidine-4-carboxaldehyde, N-BOC protected;TERT-BUTYL 4-FORMYLPIPERIDINE-1-CARBOXYLATE;1-Piperidinecarboxylic acid, 4-formyl-, 1,1-dimethylethyl ester;N-Boc-4-piperidinecarboxaldehyde
    3. CAS NO:137076-22-3
    4. Molecular Formula: C11H19NO3
    5. Molecular Weight: 213.27
    6. EINECS: 203-107-6
    7. Product Categories: Carbonyl Compounds;Heterocycles;pharmacetical;Piperidine;Aldehydes;Pyrans, Piperidines & Piperazines;Inhibitors;Building Blocks;C10-C12;C11;Chemical Synthesis;Heterocyclic Building Blocks;Organic Building Blocks;Piperidines
    8. Mol File: 137076-22-3.mol
  • Chemical Properties

    1. Melting Point: 34-40℃
    2. Boiling Point: 295.4 °C at 760 mmHg
    3. Flash Point: >110℃
    4. Appearance: /
    5. Density: 1.114 g/cm3
    6. Vapor Pressure: 0.002mmHg at 25°C
    7. Refractive Index: 1.519
    8. Storage Temp.: Hygroscopic, -20°C Freezer, Under Inert Atmosphere
    9. Solubility: Soluble in methanol.
    10. PKA: -2.13±0.40(Predicted)
    11. Sensitive: Air Sensitive
    12. CAS DataBase Reference: 1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde(CAS DataBase Reference)
    13. NIST Chemistry Reference: 1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde(137076-22-3)
    14. EPA Substance Registry System: 1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde(137076-22-3)
  • Safety Data

    1. Hazard Codes: Xi,N,Xn
    2. Statements: 36/37/38-50-22
    3. Safety Statements: 26-36/37/39-61
    4. RIDADR: UN 3077 9/PG 3
    5. WGK Germany:
    6. RTECS:
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 137076-22-3(Hazardous Substances Data)

137076-22-3 Usage

Uses

1. Used in Pharmaceutical Industry:
1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde is used as a reactant for the synthesis of various pharmaceutical compounds, including:
a) Pim-1 inhibitors for the treatment of cancer.
b) Selective GPR119 agonists for managing type II diabetes.
c) M-tropic (R5) HIV-1 replication inhibitors for combating HIV/AIDS.
d) HDAC inhibitors for the treatment of various diseases, including cancer.
e) Selective 5-HT6 antagonists for potential applications in the treatment of neurological and psychiatric disorders.
2. Used in Chemical Synthesis:
1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde is used as a reactant for three-component vinylogous Mannich reactions, which are important in the synthesis of complex organic molecules.
3. Used in the Synthesis of Polycyclic Indazole Derivatives:
1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde serves as an intermediate for the creation of polycyclic indazole derivatives, which are ERK inhibitors. These inhibitors have potential applications in the treatment of various diseases, including cancer.

Check Digit Verification of cas no

The CAS Registry Mumber 137076-22-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,7,0,7 and 6 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 137076-22:
(8*1)+(7*3)+(6*7)+(5*0)+(4*7)+(3*6)+(2*2)+(1*2)=123
123 % 10 = 3
So 137076-22-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H19NO3/c1-11(2,3)15-10(14)12-6-4-9(8-13)5-7-12/h8-9H,4-7H2,1-3H3

137076-22-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H52813)  1-Boc-piperidine-4-carboxaldehyde, 97%   

  • 137076-22-3

  • 250mg

  • 312.0CNY

  • Detail
  • Alfa Aesar

  • (H52813)  1-Boc-piperidine-4-carboxaldehyde, 97%   

  • 137076-22-3

  • 1g

  • 935.0CNY

  • Detail
  • Alfa Aesar

  • (H52813)  1-Boc-piperidine-4-carboxaldehyde, 97%   

  • 137076-22-3

  • 5g

  • 3740.0CNY

  • Detail
  • Aldrich

  • (722022)  1-Boc-piperidine-4-carboxaldehyde  95%

  • 137076-22-3

  • 722022-500MG

  • 875.16CNY

  • Detail

137076-22-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Boc-piperidine-4-carboxaldehyde

1.2 Other means of identification

Product number -
Other names 1-Boc-4-formylpiperidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:137076-22-3 SDS

137076-22-3Relevant articles and documents

A new approach to 4-aryl-1,3-butanediols by cobalt-catalyzed sequential radical cyclization-arylation reaction of silicon-tethered 6-iodo-1-hexene derivatives

Someya, Hidenori,Kondoh, Azusa,Sato, Akinori,Ohmiya, Hirohisa,Yorimitsu, Hideki,Oshima, Koichiro

, p. 3061 - 3064 (2006)

Treatment of 6-iodo-4-oxa-3-sila-1-hexene derivatives with arylmagnesium bromide in the presence of a catalytic amount of a cobalt-diamine complex in THF afforded the corresponding benzyl-substituted oxasilacyclopentanes in good yield. The products were converted to 4-aryl-1,3-diols after Tamao-Fleming oxidation. Georg Thieme Verlag Stuttgart.

An efficient synthesis of the orally-active GpIIb/IIIa antagonist FR184764

Yamanaka, Toshio,Ohkubo, Mitsuru,Takahashi, Fumie,Kato, Masayuki

, p. 2843 - 2845 (2004)

An efficient synthesis of the orally-active GpIIb/IIIa antagonist FR184764 was achieved. The key intermediate, an optically active ethynyl β-amino ester, was synthesized efficiently by utilizing a lipase catalyzed kinetic resolution step.

Synthesis and antiplasmodial activity of streptocyanine/peroxide and streptocyanine/4-aminoquinoline hybrid dyes

Maether, Marie-Pierre,Bernat, Virginie,Maturano, Marie,Andre-Barres, Christiane,Ladeira, Sonia,Valentin, Alexis,Vial, Henri,Payrastre, Corinne

, p. 7400 - 7410 (2011)

Two series of streptocyanine dyes incorporating cyclic peroxide or 4-aminoquinoline moieties are prepared and X-ray diffraction structures for three compounds are determined. All hybrid dyes show good antiplasmodial activity (0.06 to 0.66 μM) and are not

Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies

Brindisi, Margherita,Senger, Johanna,Cavella, Caterina,Grillo, Alessandro,Chemi, Giulia,Gemma, Sandra,Cucinella, Dora Mariagrazia,Lamponi, Stefania,Sarno, Federica,Iside, Concetta,Nebbioso, Angela,Novellino, Ettore,Shaik, Tajith Baba,Romier, Christophe,Herp, Daniel,Jung, Manfred,Butini, Stefania,Campiani, Giuseppe,Altucci, Lucia,Brogi, Simone

, p. 127 - 138 (2018)

This paper describes the rational development of a series of novel spiroindoline derivatives endowed with selective inhibitory activity on the HDAC6 isoform. A convenient multicomponent one-pot protocol was applied for the assembly of the desired N1-substituted spiroindoline core which allowed a straightforward analoging. Computational studies and in vitro determination of inhibitory potency for the developed compounds against HDAC6 and HDAC1 isoforms were flanked by cell-based studies on histone H3 and α-tubulin acetylation. The effects on cancer cell cycle and apoptosis of the best performing derivatives were assessed on cancer cell lines highlighting a promising antitumor potential. In view of cell-based data and calculated drug-like properties, the selective HDAC6 inhibitor 5b, with a spiroindoline-based hydroxamate bearing a tert-butyl carbamate functionality, was selected to be further investigated for its potential in inhibiting tumor cells migration. It was able to potently inhibit cell migration in SH-SY5Y neuroblastoma cells and did not display toxicity in NIH3T3 mouse fibroblasts. Taken together, these data foster further investigation and optimization for this class of compounds as novel anticancer agents.

Piperidine-based glycodendrons as protein N-glycan prosthetics

Hudak, Jason E.,Belardi, Brian,Appel, Mason J.,Solania, Angelo,Robinson, Peter V.,Bertozzi, Carolyn R.

, p. 4791 - 4800 (2016)

The generation of homogeneously glycosylated proteins is essential for defining glycoform-specific activity and improving protein-based therapeutics. We present a novel glycodendron prosthetic which can be site-selectively appended to recombinant proteins to create ‘N-glycosylated’ glycoprotein mimics. Using computational modeling, we designed the dendrimer scaffold and protein attachment point to resemble the native N-glycan architecture. Three piperidine–melamine glycodendrimers were synthesized via a chemoenzymatic route and attached to human growth hormone and the Fcregion of human IgG. These products represent a new class of engineered biosimilars bearing novel glycodendrimer structures.

A CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DEGRADATION OF ANDROGEN RECEPTORS AND USE THEREOF

-

, (2022/03/07)

The present invention relates to a class of bifunctional chimeric heterocyclic compounds for targeted degradation of androgen receptors and use thereof, and specifically provides a compound of formula (I), or an isotopic compound thereof, or an optical isomer thereof, or a tautomer thereof, or a pharmacologically acceptable salt thereof, or a prodrug thereof, or a solvate thereof, wherein ARB is an androgen receptor recognition/binding part, L is a link part, and U is a ubiquitin protease recognition/binding part; and the three parts are connected by means of chemical bonds. The compound can perform the targeted degradation on androgen receptors in prostate cancer cells, and suppress the proliferation of the prostate cancer cells, and also show good metabolic stability and pharmacokinetic properties. The compound has good application prospect in the preparation of targeted chimeras for protein degradation of androgen receptors and in the preparation of drugs for treating the related diseases regulated by the androgen receptors.

C-H Alkylation of Aldehydes by Merging TBADT Hydrogen Atom Transfer with Nickel Catalysis

Murugesan, Vetrivelan,Ganguly, Anirban,Karthika, Ardra,Rasappan, Ramesh

, p. 5389 - 5393 (2021/07/21)

Catalyst controlled site-selective C-H functionalization is a challenging but powerful tool in organic synthesis. Polarity-matched and sterically controlled hydrogen atom transfer (HAT) provides an excellent opportunity for site-selective functionalization. As such, the dual Ni/photoredox system was successfully employed to generate acyl radicals from aldehydes via selective formyl C-H activation and subsequently cross-coupled to generate ketones, a ubiquitous structural motif present in the vast majority of natural and bioactive molecules. However, only a handful of examples that are constrained to the use of aryl halides are developed. Given the wide availability of amines, we developed a cross-coupling reaction via C-N bond cleavage using the economic nickel and TBADT catalyst for the first time. A range of alkyl and aryl aldehydes were cross-coupled with benzylic and allylic pyridinium salts to afford ketones with a broad spectrum of functional group tolerance. High regioselectivity toward formyl C-H bonds even in the presence of α-methylene carbonyl or α-amino/oxy methylene was obtained.

BIFUNCTIONAL MOLECULES CONTAINING AN E3 UBIQUITINE LIGASE BINDING MOIETY LINKED TO A BCL6 TARGETING MOIETY

-

Paragraph 00475; 00476, (2021/04/23)

Bifunctional compounds, which find utility as modulators of B-cell lymphoma 6 protein (BCL6; target protein), are described herein. In particular, the bifunctional compounds of the present disclosure contain on one end a Von Hippel-Lindau, cereblon, Inhibitors of Apotosis Proteins or mouse double-minute homolog 2 ligand that binds to the respective E3 ubiquitin ligase and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The bifunctional compounds of the present disclosure exhibit a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

Expansion of substrate scope for nitroxyl radical/copper-catalyzed aerobic oxidation of primary alcohols: A guideline for catalyst selection

Iwabuchi, Yoshiharu,Nagasawa, Shota,Sasaki, Ryota,Sasano, Yusuke,Yamaichi, Aoto

, p. 488 - 497 (2021/05/27)

Four distinctive sets of optimum nitroxyl radical/copper salt/additive catalyst combinations have been identified for accommodating the aerobic oxidation of various types of primary alcohols to their corresponding aldehydes. Interestingly, less nucleophilic catalysts exhibited higher catalytic activities for the oxidation of particular primary allylic and propargylic alcohols to give α,β-unsaturated aldehydes that function as competent Michael acceptors. The optimum conditions identified herein were successful in the oxidation of various types of primary alcohols, including unprotected amino alcohols and divalent-sulfur-containing alcohols in good-to-high yields. Moreover, N-protected alaninol, an inefficient substrate in the nitroxyl radical/ copper-catalyzed aerobic oxidation, was oxidized in good yield. On the basis of the optimization results, a guideline for catalyst selection has been established.

1,3-Alkyl Transposition in Allylic Alcohols Enabled by Proton-Coupled Electron Transfer

Knowles, Robert R.,Seidler, Gesa,Zhao, Kuo

supporting information, p. 20190 - 20195 (2021/08/13)

A method is described for the isomerization of acyclic allylic alcohols into β-functionalized ketones via 1,3-alkyl transposition. This reaction proceeds via light-driven proton-coupled electron transfer (PCET) activation of the O?H bond in the allylic al

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 137076-22-3